Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anti-CD3 monoclonal antibodies. Characterization and function].

D Bourel1, N Genetet, G Merdrignac

  • 1Centre Régionale de Transfusion Sanguine, Rennes, France.

Pathologie-Biologie
|December 1, 1987
PubMed
Summary

Four new monoclonal antibodies targeting T lymphocytes were developed. These antibodies demonstrate reactivity comparable to anti-CD3 reagents, aiding the study of T-lymphocyte activation and immune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Not Available].

Revue de synthese·2010
Same author

Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro.

Clinical and experimental immunology·2007
Same author

Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk.

Clinical and experimental immunology·2006
Same author

[Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].

Journal de gynecologie, obstetrique et biologie de la reproduction·2006
Same author

Doxorubicin induces Fas-mediated apoptosis in human thyroid carcinoma cells.

Thyroid : official journal of the American Thyroid Association·2004
Same author

The rescue by phage display of human Fabs to gp120 HIV-1 glycoprotein using EBV transformed lymphocytes.

Molecular biotechnology·2001

Area of Science:

  • Immunology
  • Cell Biology

Context:

  • The T-lymphocyte receptor (TCR) complex, particularly the CD3 molecule, is crucial for T-cell activation and immune response initiation.
  • Characterizing novel reagents that interact with the CD3 complex is essential for advancing our understanding of cellular immunity.

Purpose:

  • To produce and characterize novel monoclonal antibodies targeting T lymphocytes.
  • To evaluate the reactivity and specificity of these antibodies against the CD3 cluster using various immunological assays.

Summary:

  • Four anti-T lymphocyte monoclonal antibodies were generated using the hybridoma technique.
  • Flow cytometry, cell sorting, and blocking experiments confirmed their reactivity profile, comparable to established anti-CD3 monoclonal antibodies.
  • Biochemical and functional analyses, including modulation effects and mitogenic properties, supported their classification within the CD3 cluster.

Related Experiment Videos

Impact:

  • These novel anti-CD3 antibodies provide valuable tools for dissecting T-lymphocyte activation pathways.
  • They can enhance research into immune responses and related disorders.
  • Further investigation of these reagents will contribute to a deeper understanding of T-cell immunology.